Table 4.
No. of studies | RR (95% CI) | I2 | P -value | |
---|---|---|---|---|
Overall | ||||
Total adverse reactions | 3 | 1.00 [0.99, 1.02] | 90 | >0.05 |
Local adverse reactions | 3 | 1.02 [1.00, 1.04] | 82 | <0.05* |
Systemic adverse reactions | 3 | 0.83 [0.81, 0.86] | 96 | <0.05* |
Overall | 6 | 0.73 [0.71, 0.74] | 97 | >0.05 |
Local pain | 6 | 1.02 [1.00, 1.04] | 73 | P = 0.05 |
Erythema/ Redness | 5 | 0.70 [0.62, 0.79] | 0 | <0.05* |
Induration | 1 | 2.00 [0.18, 21.71] | Not applicable | >0.05 |
Pruritus/ Itch | 3 | 1.15 [0.39, 3.41] | 0 | >0.05 |
Swelling | 6 | 0.79 [0.70, 0.89] | 0 | <0.05* |
Axillary Swelling | 1 | 1.11 [1.00, 1.23] | Not applicable | P = 0.05 |
Fever | 6 | 0.44 [0.37, 0.53] | 95 | <0.05* |
Cough | 3 | 1.76 [0.99, 3.12] | 0 | P = 0.05 |
Oropharyngeal pain | 1 | 3.00 [0.32, 28.35] | Not applicable | >0.05 |
Headache | 6 | 0.65 [0.62, 0.69] | 65 | <0.05* |
Fatigue | 6 | 0.72 [0.69, 0.76] | 39 | <0.05* |
Myalgia | 6 | 0.59 [0.55, 0.64] | 39 | <0.05* |
Arthralgia | 4 | 0.52 [0.47, 0.58] | 0 | <0.05* |
Nausea/ vomiting | 1 | 0.47 [0.42, 0.54] | Not applicable | <0.05* |
Nausea | 3 | 1.24 [0.49, 3.11] | 0 | >0.05 |
Vomiting | 5 | 1.26 [0.58, 2.78] | 0 | >0.05 |
Diarrhea | 4 | 1.45 [0.72, 2.94] | 0 | >0.05 |
Anorexia | 2 | 1.81 [0.68, 4.83] | 32 | >0.05 |
Chills | 3 | 0.44 [0.40, 0.48] | 41 | <0.05* |
Pruritus (systemic adverse reaction) | 1 | 3.00 [0.12, 72.77] | Not applicable | >0.05 |
Acute allergic reaction/ Hypersensitivity | 1 | 0.33 [0.01, 8.13] | Not applicable | >0.05 |
Abnormal skin and mucosa | 1 | 2.92 [0.31, 28.00] | Not applicable | >0.05 |
Dysphagia | 1 | 0.33 [0.01, 8.09] | Not applicable | >0.05 |
P < 0.05.